Radiation Therapy in the Oncology Market Size, Share, Trends, & Industry Analysis Report: By Radiation Type (External Beam Radiation and Internal Beam Radiation), By Therapy, By End-User, and By Region

Description

List of Tables

The global Radiation therapy in the oncology market size is expected to reach USD 15.43 billion by 2034, according to a new study by Polaris Market Research. The report "Radiation Therapy in the Oncology Market Size, Share, Trends, Industry Analysis Report: By Radiation Type (External Beam Radiation and Internal Beam Radiation), Therapy, End-User, and Region- Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Radiation therapy in the oncology market encompasses the utilization of high-energy ionizing radiation to treat and manage cancer. This therapeutic modality involves precisely delivering radiation to malignant tumors, aiming to eradicate cancerous cells or impede their growth while minimizing damage to surrounding healthy tissues and organs. Various radiation sources and delivery techniques are employed, including external beam radiation therapy (EBRT) using linear accelerators, internal radiation therapy (brachytherapy) involving the placement of radioactive sources within the body, and systemic radiation therapy using radioactive substances that circulate throughout the body. The radiation oncology field integrates sophisticated imaging, treatment planning software, and specialized medical expertise to optimize treatment outcomes for cancer patients across diverse tumor types and stages.

The market is a critical segment within the broader radiation oncology landscape, driven by the increasing global incidence of cancer and continuous advancements in radiation delivery technologies. The market overview reveals a dynamic environment influenced by factors such as the growing adoption of personalized medicine, which tailors radiation treatments to individual patient and tumor characteristics. Technological innovations, including intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), proton therapy, and magnetic resonance-guided radiation therapy (MRgRT), are enhancing treatment precision and efficacy, thereby fueling market development. Furthermore, the expanding healthcare infrastructure in emerging economies and the rising demand for minimally invasive cancer treatment options contribute significantly to the overall market growth and market potential of radiation therapy in oncology.

Radiation Therapy in the Oncology Market Report Highlights:

By radiation type, the external beam radiation segment currently holds the highest market share globally due to its broad applicability across a wide range of cancer types and the widespread availability of treatment centers equipped with this technology. Its non-invasive nature and established clinical protocols contribute to its dominant position in the radiation therapy market.

By therapy, intensity-modulated radiation therapy (IMRT) presently commands the largest market share. This is primarily because of its advanced capability to precisely conform the radiation dose to the tumor's shape while modulating the beam's intensity, leading to widespread adoption across various cancer treatments and its proven efficacy in improving local control.

By end-user, the hospitals & medical research institutes segment currently accounts for the largest market share. This is mainly due to the comprehensive cancer care services offered by hospitals, where radiation therapy is a fundamental treatment modality, along with the significant patient volumes they handle and the research activities undertaken by medical research institutes.

By region, North America currently holds the largest market share in the radiation therapy in the oncology market. The Asia Pacific region is anticipated to exhibit the highest growth rate in the radiation therapy in the oncology market over the forecast period.

The major players actively involved in the radiation therapy in the oncology market, who have not been acquired, include Accuray Incorporated, Elekta AB, Mevion Medical Systems, Siemens Healthineers (which includes Varian Medical Systems), IBA Worldwide, ViewRay Technologies Inc, Perspective Therapeutics Inc (formerly Isoray Inc), Hitachi Ltd (part of Hitachi High-Tech Corporation), Sumitomo Heavy Industries Ltd, and Carl Zeiss Meditec AG (a subsidiary of Carl Zeiss AG).

Polaris Market Research has segmented the Radiation Therapy in the Oncology market report based on radiation type, therapy, end-user, and region:

By Radiation Type Outlook (Revenue - USD Billion, 2020-2034)

External Beam Radiation

Internal Beam Radiation

By Therapy Outlook (Revenue - USD Billion, 2020-2034)

Stereotactic Radiosurgery (SRS)

Image-Guided Radiation Therapy (IGRT)

Intensity-Modulated Radiation Therapy (IMRT)

Volumetric-Modulated Arc Therapy (VMAT)

Brachytherapy

By End-User Outlook (Revenue - USD Billion, 2020-2034)

Hospitals & Medical Research Institutes

Specialized Radiotherapy Centers

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

Canada

Mexico

Europe

Germany

France

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Brazil

Argentina

Rest of Latin America

Product Code: PM5746

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source

4. Global Radiation Therapy in the Oncology Market Insights

4.1. Radiation Therapy in the Oncology Market - Market Snapshot
4.2. Radiation Therapy in the Oncology Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increasing Global Cancer Incidence Driving Market Demand
  - 4.2.1.2. Technological Advancements Enhancing Treatment Efficacy
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High cost of radiation equipment
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Radiation Therapy in the Oncology Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Radiation Therapy in the Oncology Market, by Radiation Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
5.3. External Beam Radiation
- 5.3.1. Global Radiation Therapy in the Oncology Market, by External Beam Radiation, by Region, 2020-2034 (USD Billion)
5.4. Internal Beam Radiation
- 5.4.1. Global Radiation Therapy in the Oncology Market, by Internal Beam Radiation, by Region, 2020-2034 (USD Billion)

6. Global Radiation Therapy in the Oncology Market, by Therapy

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
6.3. Stereotactic Radiosurgery (SRS)
- 6.3.1. Global Radiation Therapy in the Oncology Market, by Stereotactic Radiosurgery (SRS), by Region, 2020-2034 (USD Billion)
6.4. Image-Guided Radiation Therapy (IGRT)
- 6.4.1. Global Radiation Therapy in the Oncology Market, by Image-Guided Radiation Therapy (IGRT), by Region, 2020-2034 (USD Billion)
6.5. Intensity-Modulated Radiation Therapy (IMRT)
- 6.5.1. Global Radiation Therapy in the Oncology Market, by Intensity-Modulated Radiation Therapy (IMRT), by Region, 2020-2034 (USD Billion)
6.6. Volumetric-Modulated Arc Therapy (VMAT)
- 6.6.1. Global Radiation Therapy in the Oncology Market, by Volumetric-Modulated Arc Therapy (VMAT), by Region, 2020-2034 (USD Billion)
6.7. Brachytherapy
- 6.7.1. Global Radiation Therapy in the Oncology Market, by Brachytherapy, by Region, 2020-2034 (USD Billion)

7. Global Radiation Therapy in the Oncology Market, by End-User

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
7.3. Hospitals & Medical Research Institutes
- 7.3.1. Global Radiation Therapy in the Oncology Market, by Hospitals & Medical Research Institutes, by Region, 2020-2034 (USD Billion)
7.4. Specialized Radiotherapy Centers
- 7.4.1. Global Radiation Therapy in the Oncology Market, by Specialized Radiotherapy Centers, by Region, 2020-2034 (USD Billion)

8. Global Radiation Therapy in the Oncology Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Radiation Therapy in the Oncology Market Assessment, By Geography, 2020-2034 (USD Billion)
8.3. Radiation Therapy in the Oncology Market - North America
- 8.3.1. North America: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.3.2. North America: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.3.3. North America: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.3.4. Radiation Therapy in the Oncology Market - U.S.
  - 8.3.4.1. U.S.: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.3.4.2. U.S.: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.3.4.3. U.S.: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.3.5. Radiation Therapy in the Oncology Market - Canada
  - 8.3.5.1. Canada: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.3.5.2. Canada: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.3.5.3. Canada: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
8.4. Radiation Therapy in the Oncology Market - Europe
- 8.4.1. Europe: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.4.2. Europe: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.4.3. Europe: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.4.4. Radiation Therapy in the Oncology Market - UK
  - 8.4.4.1. UK: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.4.4.2. UK: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.4.4.3. UK: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.4.5. Radiation Therapy in the Oncology Market - France
  - 8.4.5.1. France: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.4.5.2. France: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.4.5.3. France: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.4.6. Radiation Therapy in the Oncology Market - Germany
  - 8.4.6.1. Germany: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.4.6.2. Germany: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.4.6.3. Germany: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.4.7. Radiation Therapy in the Oncology Market - Italy
  - 8.4.7.1. Italy: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.4.7.2. Italy: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.4.7.3. Italy: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.4.8. Radiation Therapy in the Oncology Market - Spain
  - 8.4.8.1. Spain: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.4.8.2. Spain: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.4.8.3. Spain: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.4.9. Radiation Therapy in the Oncology Market - Netherlands
  - 8.4.9.1. Netherlands: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.4.9.2. Netherlands: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.4.9.3. Netherlands: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.4.10. Radiation Therapy in the Oncology Market - Russia
  - 8.4.10.1. Russia: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.4.10.2. Russia: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.4.10.3. Russia: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.4.11. Radiation Therapy in the Oncology Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.4.11.2. Rest of Europe: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.4.11.3. Rest of Europe: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
8.5. Radiation Therapy in the Oncology Market - Asia Pacific
- 8.5.1. Asia Pacific: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.5.4. Radiation Therapy in the Oncology Market - China
  - 8.5.4.1. China: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.5.4.2. China: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.5.4.3. China: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.5.5. Radiation Therapy in the Oncology Market - India
  - 8.5.5.1. India: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.5.5.2. India: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.5.5.3. India: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.5.6. Radiation Therapy in the Oncology Market - Malaysia
  - 8.5.6.1. Malaysia: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.5.6.2. Malaysia: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.5.6.3. Malaysia: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.5.7. Radiation Therapy in the Oncology Market - Japan
  - 8.5.7.1. Japan: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.5.7.2. Japan: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.5.7.3. Japan: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.5.8. Radiation Therapy in the Oncology Market - Indonesia
  - 8.5.8.1. Indonesia: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.5.8.2. Indonesia: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.5.8.3. Indonesia: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.5.9. Radiation Therapy in the Oncology Market - South Korea
  - 8.5.9.1. South Korea: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.5.9.2. South Korea: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.5.9.3. South Korea: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.5.10. Radiation Therapy in the Oncology Market - Australia
  - 8.5.10.1. Australia: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.5.10.2. Australia: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.5.10.3. Australia: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.5.11. Radiation Therapy in the Oncology Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.5.11.2. Rest of Asia Pacific: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.5.11.3. Rest of Asia Pacific: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
8.6. Radiation Therapy in the Oncology Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.6.4. Radiation Therapy in the Oncology Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.6.4.2. Saudi Arabia: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.6.4.3. Saudi Arabia: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.6.5. Radiation Therapy in the Oncology Market - UAE
  - 8.6.5.1. UAE: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.6.5.2. UAE: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.6.5.3. UAE: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.6.6. Radiation Therapy in the Oncology Market - Israel
  - 8.6.6.1. Israel: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.6.6.2. Israel: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.6.6.3. Israel: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.6.7. Radiation Therapy in the Oncology Market - South Africa
  - 8.6.7.1. South Africa: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.6.7.2. South Africa: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.6.7.3. South Africa: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.6.8. Radiation Therapy in the Oncology Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.6.8.2. Rest of Middle East & Africa: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.6.8.3. Rest of Middle East & Africa: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
8.7. Radiation Therapy in the Oncology Market - Latin America
- 8.7.1. Latin America: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.7.4. Radiation Therapy in the Oncology Market - Mexico
  - 8.7.4.1. Mexico: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.7.4.2. Mexico: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.7.4.3. Mexico: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.7.5. Radiation Therapy in the Oncology Market - Brazil
  - 8.7.5.1. Brazil: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.7.5.2. Brazil: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.7.5.3. Brazil: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.7.6. Radiation Therapy in the Oncology Market - Argentina
  - 8.7.6.1. Argentina: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.7.6.2. Argentina: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.7.6.3. Argentina: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.7.7. Radiation Therapy in the Oncology Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.7.7.2. Rest of Latin America: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.7.7.3. Rest of Latin America: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Accuray Incorporated
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Carl Zeiss Meditec AG (a subsidiary of Carl Zeiss AG)
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Elekta AB
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Hitachi Ltd (part of Hitachi High-Tech Corporation)
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. IBA Worldwide
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Mevion Medical Systems
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Perspective Therapeutics Inc (formerly Isoray Inc)
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Siemens Healthineers (which includes Varian Medical Systems)
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Sumitomo Heavy Industries Ltd
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. ViewRay Technologies Inc
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development